Volume 7, Issue 3, May 2019, Page: 76-80
Hyperthyroid Fetal Goiter: A Case Report
Vedi Loue, Sud Francilien Hospital Center (Woman-Mother-Child Pole), Paris Descartes University, Paris, France; Faculty of Medical Sciences (Mother and Child Department, University Hospital of Cocody), Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire
Mamadou Traore, Sud Francilien Hospital Center (Woman-Mother-Child Pole), Paris Descartes University, Paris, France
Charles Kacou, Faculty of Medical Sciences (Mother and Child Department, University Hospital of Cocody), Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire
Arthur Kouame, Faculty of Medical Sciences (Mother and Child Department, University Hospital of Cocody), Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire
Eleonore Gbary-Lagaud, Faculty of Medical Sciences (Mother and Child Department, University Hospital of Cocody), Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire
Julie Grevoul-Fesquet, Sud Francilien Hospital Center (Woman-Mother-Child Pole), Paris Descartes University, Paris, France
Received: Dec. 5, 2018;       Accepted: Feb. 1, 2019;       Published: Jun. 11, 2019
DOI: 10.11648/j.jgo.20190703.14      View  10      Downloads  5
Abstract
The persistent presence of maternal thyroid-stimulating hormone receptor antibody in patients with Graves’disease could cause fetal hyperthyroid goiter during pregnancy. The recognition and treatment of hyperthyroid fetal goiter are believed to be very important to optimize growth and intellectual development in affected fetuses. We report here, a case of a hyperthyroid fetal goiter identified by ultrasound exam at 27 weeks 5 days of gestation in a women having Graves’ disease and on antithyroid drugs therapy. This observation shows the fetal risk associated with the persistence of anti-TSH receptor antibodies in mothers with Graves' disease and the possibility of fetal approach.
Keywords
Graves’ Disease, Thyroid Hormones, Fetal Hyperthyroid Goiter, Prenatal Diagnosis
To cite this article
Vedi Loue, Mamadou Traore, Charles Kacou, Arthur Kouame, Eleonore Gbary-Lagaud, Julie Grevoul-Fesquet, Hyperthyroid Fetal Goiter: A Case Report, Journal of Gynecology and Obstetrics. Vol. 7, No. 3, 2019, pp. 76-80. doi: 10.11648/j.jgo.20190703.14
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Aynadis Alemu, Betelihem Terefe, Molla Abebe, Belete Biadgo. Thyroid hormone dysfunction during pregnancy: A review. Int J Reprod BioMed 2016; 14, 11: 677-86.
[2]
Kazakou P,Theodora M, Kanaka-Gantenbein C,et al. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report. Case Reports in Women's Health 2018; 19: e00081.
[3]
Andersen SL, Laurberg P. Managing hyperthyroidism in pregnancy: current perspectives. International Journal of Women’s Health 2016: 8 497-504.
[4]
Kurtoğlu S, Özdemir A. Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment. Turk Pediatri Ars 2017; 52: 1-9.
[5]
De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016; 388 (10047): 906-918.
[6]
Nguyen CT, Sasso EB, Barton L, Mestman JH. Graves’ hyperthyroidism in pregnancy: a clinical review. Clinical Diabetes and Endocrinology 2018; 4:4.
[7]
Bucci I, Giuliani C, Napolitano G. Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance. Frontiers in Endocrinology 2017; 8: 137.
[8]
Banige M, Estellat C, Biran V, et al. Study of the Factors Leading to Fetal and Neonatal Dysthyroidism in Children of Patients With Graves Disease. Journal of the Endocrine Society 2017; 1,6: 751-61.
[9]
Léger J. Management of Fetal and Neonatal Graves' Disease. Horm Res Paediatr. 2017; 87 (1): 1-6.
[10]
Taff C. Prenatal diagnosis and treatment of fetal goiter. J Diagnosis Medical Sonography 2016; 32, 1: 40-3.
[11]
Neto JFG, Junior EA, Costa JIF, et al. Fetal goiter conservatively monitored during the prenatal period associated with maternal and neonatal euthyroid status. Obstet Gynecol Sci 2016; 59, 1: 54-7.
[12]
Mastrolia SA, Mandola A, Mazor M, et al. Prenatal diagnosis and treatment perspective of fetal hypothyroidism with goiter. J Matern Fetal Neonatal Med 2015; 28(18):2214-20.
[13]
Min-Jung Kim, Yong-Hwa Chae, So-Young Park, Moon-Young Kim. Intra-amniotic thyroxine to treat fetal goiter. Obstet Gynecol Sci 2016;59(1):66-70.
[14]
Song R, Lin H, Chen Y, Zhang X, Feng W. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A metaanalysis. PloS ONE 2017; 12(7): e0180108.
Browse journals by subject